PRoMiSS: Psilocybin and the Role of Music in Set and Setting
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT07180108
- Phase
- PHASE1
- Status
- Enrolling By Invitation
Conditions
- Music Intervention
- Psilocybin
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Psilocybin (high dose) — DRUG25 mg pill
- Playlist 1 — BEHAVIORALSix hour playlist
- Playlist 2 — BEHAVIORALA six hour playlist
- Playlist 3 — BEHAVIORALA six hour playlist
- Playlist 4 — BEHAVIORALA six hour playlist
- Playlist 5 — BEHAVIORALA six hour playlist
Study Details
The goal of this clinical trial is to understand how personally meaningful, autobiographically salient music compares to standardized playlists when combined with psilocybin in healthy adults ages 21 to 75. The main questions it aims to answer are: Does autobiographically salient music lead to stronger emotional responses to music, greater acute subjective effects, and more lasting improvements in mood, affect, and well-being compared to standardized or ambient playlists? How are brain and body responses - including EEG activity, respiration, heart rate, and skin conductance - influenced by autobiographically salient music under psilocybin? Do brain and body responses to specific music features differ when the music is autobiographically salient compared to non-salient playlists? Researchers will compare five music conditions: three conditions where an 80-minute block of autobiographically salient music is placed at different points in the 6-hour psilocybin session (0-80 minutes, 80-160 minutes, or 240-320 minutes), a standardized Johns Hopkins psilocybin playlist, and an ambient playlist with no autobiographical content. Participants will: * Take a single oral dose of psilocybin (25 mg) during one study session * Listen to one of the five music conditions while reclining in a comfortable setting * Complete questionnaires about emotions, acute, subjective effects, insight, etc. * Undergo EEG and physiological monitoring (respiration, heart rate, skin conductance) during the session * Complete MRI brain scans before the session and 1 week after psilocybin * Return for follow-ups at 1 day, 1 week, and 1 month after psilocybin * At 1 month, complete a qualitative interview and a nondrug EEG music listening session, where the participant's hear either music from the participant's own psilocybin session or music from another participant's session
Key Dates
- Start date
- Aug 12, 2025
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2028
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: 6 hour playlist of musicA 6 hour playlist of music.
Primary Outcome Measure
Challenging Experiences Questionnaire [ Time Frame: Immediately at the end of their experimental session ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center for Psychedelics and Consciousness Research in the Behavioral Biology Research Center | Baltimore | Maryland | 21224 | - |
Find similar trials in Baltimore, MD
Related Studies
- The RECAP2 Study: Midazolam and PsilocybinPHASE1 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- NeuroGuard: Psilocybin Trial for Preventing Chemo-induced NeuropathyPHASE2 · Not Yet Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Psilocybin-Assisted Physical Therapy in Chronic Low Back PainPHASE2 · Not Yet Recruiting · Yale University · New Haven, Connecticut
- Group PACBT for DepressionPHASE2 · Not Yet Recruiting · University of California, Los Angeles · Los Angeles, California